Wang Jue, Gao Qin, Shen Jia, Ye Ting-Mei, Xia Qiang
Department of Physiology, Zhejiang Medical College, Hangzhou 310053, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jan;36(1):41-7. doi: 10.3785/j.issn.1008-9292.2007.01.007.
To investigate the effect of kappa-Opioid receptors in the cardioprotection elicited by ischemic postconditioning and the underlying mechanism.
The isolated perfused hearts of male Sprague-Dawley rats were subjected to 30 min of global ischemia followed by 120 min of reperfusion. formazan content of myocardium was measured spectrophotometrically, and the level of lactate dehydrogenase (LDH) in the coronary effluent was also measured. In isolated ventricular myocytes hypoxia postconditioning was achieved by 3 cycles of 5 min reoxygenation/5 min hypoxia starting at the beginning of reoxygenation, and cell viability was measured.
In the Langendorff perfused rat heart model, ischemic postconditioning (6 cycles of 10 s reperfusion/10 s global ischemia starting at the beginning of reperfusion) increased formazan content, reduced LDH release, improved the recovery of the left ventricular developed pressure, maximal rise/fall rate of left ventricular pressure, left ventricular end-diastolic pressure and rate pressure product (left ventricular developed pressure multiplied by heart rate), attenuated the decrease of coronary flow during reperfusion and increased the isolated cell viability. Pretreatment with nor-BNI, an antagonist of kappa-Opioid receptors and mitoK(ATP) blocker 5-HD attenuated the effect of ischemic/hypoxic postconditioning.
Postconditioning may protect myocardium against ischemia/reperfusion injury via activating kappa-Opioid receptors and mitoK(KATP).
研究κ-阿片受体在缺血后处理所引发的心脏保护作用中的影响及其潜在机制。
对雄性Sprague-Dawley大鼠的离体灌注心脏进行30分钟全心缺血,随后再灌注120分钟。采用分光光度法测定心肌中噻唑蓝含量,并检测冠脉流出液中乳酸脱氢酶(LDH)水平。在离体心室肌细胞中,于复氧开始时通过5分钟复氧/5分钟缺氧的3个循环实现缺氧后处理,并检测细胞活力。
在Langendorff灌注大鼠心脏模型中,缺血后处理(于再灌注开始时进行6个循环的10秒再灌注/10秒全心缺血)增加了噻唑蓝含量,减少了LDH释放,改善了左心室舒张末压、左心室压力最大上升/下降速率、左心室舒张末压和心率压力乘积(左心室舒张末压乘以心率)的恢复情况,减轻了再灌注期间冠脉流量的减少,并提高了分离细胞的活力。用κ-阿片受体拮抗剂nor-BNI和线粒体ATP敏感性钾通道(mitoK(ATP))阻滞剂5-HD预处理可减弱缺血/缺氧后处理的作用。
后处理可能通过激活κ-阿片受体和mitoK(KATP)来保护心肌免受缺血/再灌注损伤。